"We hope we've identified a potential approach for accelerating myelin repair with pharmacological means," says Andreas Faissner, Head of the Department of Cell Morphology and Molecular Neurobiology in Bochum.

Complex manufacturing mechanism

The myelin sheath is formed by specific cells, namely oligodendrocytes. "In order for the insulation layer to be generated, the cell shape and its membrane extensions require complex changes," explains Faissner. In their current project, the research team analysed molecular switches that regulate the shape of the cell. To this end, the Bochum-based group collaborated with the Centre for Regenerative Medicine, University of Edinburgh, the Institute of Neuropathology at the university clinic in Münster, and the Department of Cellular Neurophysiology at Hanover Medical School.

Slower regeneration without exchange factor Vav3

In their study, the researchers demonstrated the significance of the Vav3 signalling molecule. It regulates the activity of other molecules, which act as molecular switches by activating and deactivating certain signalling processes. The researchers showed that the activity of molecular switches was altered in oligodendrocytes that lack the Vav3 exchange factor. Moreover, they analysed in what way a missing Vav3 affected the regeneration of the myelin sheath in cultivated cells whose insulation layer had been damaged. The result: without Vav3, the new myelin layer formed more slowly than in cell cultures with Vav3. These findings were confirmed in experiments on mice that lacked Vav3 and that likewise presented slower myelin regeneration.

The signalling mechanisms of molecular switches of the RhoA type, which were under scrutiny here, have been fairly comprehensively investigated. "Combined with our understanding of how important the Vav3 exchange factor is, it might be possible in future to control the molecular switches in such a way as to accelerate the regeneration of the myelin sheath," concludes Faissner.